Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-05-10 00:00:00 ET · period of report 2023-05-08 · accession 0001209191-23-028504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-10 | 2023-05-08 | DLB | Rollins Emily | Dir | S - Sale | $84.70 | -1,000 | 5,541 | -15% | -$84.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-08 | S | D | 1,000 | $84.70 | 5,541 | D | — | — | (F1) Shares held following the reported transaction include 3,296 restricted stock units, which are subject to forfeiture until they vest. |